Loading clinical trials...
Loading clinical trials...
Multinational, Multicenter, Prospective, Long-term Safety and Efficacy Follow-up Study After Autologous Cultivated Limbal Stem Cells Transplantation (ACLSCT) for Restoration of Corneal Epithelium in Patients With Limbal Stem Cell Deficiency Due to Ocular Burns
Conditions
Interventions
Ophthalmologic examinations
Digital pictures
+1 more
Locations
1
Italy
Hospital San Raffaele
Milan, Italy
Start Date
December 13, 2017
Primary Completion Date
March 31, 2023
Completion Date
March 31, 2023
Last Updated
May 26, 2023
Lead Sponsor
Holostem s.r.l.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions